Biography

Kathy has enjoyed a broad range of experiences in the Portland legal community since 1994. With skills developed in banking and accounting, she joined a small general practice. Following completion of her paralegal certificate, she began work as a legal secretary in a midsize firm, where, with encouragement from a senior partner, she became a litigation paralegal focusing in defense of personal injury, toxic tort, and professional liability claims. She was with Friedman Gaythwaite Wolf in 2013 and became a part of the Verrill team when the firms combined.

Kathy supports the Litigation & Trial Group in the areas of Professional Liability & Licensure, Health Care Litigation, Product Liability, and Toxic Torts & Personal Injury Defense from initial assessment through appeal. She assists counsel in all phases of the discovery process, analyzes and summarizes medical records, and interviews witnesses. She enjoys researching expert witness databases, medical issues, and federal, state, and local law. She works with the Litigation & Trial team to prepare for depositions, mediations, panel hearings, and trials. Kathy directs her strong organizational and analytical skills to support the litigators in successfully representing Verrill's clients.

Services/Industries

Education

  • University of Southern Maine  (Paralegal Certificate)
  • University of Southern Maine  (B.S.)

Firm Highlights

Blog

Commercial Co-Ventures: What You Need to Know During a Pandemic

Matter

Management Inefficiency

Verrill represented Emera in its 2017 distribution rate case before the Maine PUC, which included: defeating Staff's proposed reduction to allowed return on equity for "management inefficiency;" approval of new expenditures, such as an...

News

Maine's 'Thoughtful' and 'Aggressive' Response to COVID-19

On Wednesday, April 8, the Portland Regional Chamber of Commerce had its first ever virtual Eggs & Issues, moderated by Jim Cohen, volunteer board president of the Portland Community Chamber of Commerce and Verrill...

Blog

Financial Institutions . . . In the News

Hundreds of business owners filing federal aid applications with lenders. ( Portland Press Herald 4.6.2020) Maine Securities Administrator Judith Shaw cautions to be careful of scammers. ( Central Maine 4.6.2020) New Dimensions Federal Credit...

Publication/Podcast

Executive Order Temporarily Modifies Requirements for In-Person Notarization and Acknowledgement in Maine

On April 8, 2020, Maine Governor Janet Mills signed an Executive Order titled “An Order Temporarily Modifying Certain In-Person Notarization and Acknowledgement Requirements.” The purpose of this Order is to enable citizens to execute...

Event

Central Maine Human Resources Association Chapter Meeting: Flexible Work Options

Employment and labor attorney Tawny Alvarez will be presenting at the Central Maine Human Resources Association Chapter Meeting. This month's chapter meeting will focus on flexible work options. Tawny will discuss how policy impacts...

Publication/Podcast

Should Health Care Employers Prepare for COVID-19 As A Work-Related Injury?

While we know that everyone is being bombarded with COVID-19 recommendations, advice, news, and data, another important issue to manage in the workplace is the possibility of COVID-19 infection, if acquired at work and...

Matter

Management Audit

Verrill represented Emera in its 2016 distribution rate case before the Maine PUC. The case involved issues relating to significant new capital investments, including Emera's new customer information system and a controversial substation investment...

Event

2020 OHRP Exploratory Workshop

Health care attorney Emily Fogler will be presenting at the 2020 OHRP Exploratory Workshop in the third session, discussing sharing responsibilities and protecting participants - redefining roles in the single IRB era. Stay tuned...

News

Available Take-Home Methadone Doses for Patients

Attorney Jim Cohen was mentioned in a Portland Press Herald article, "Methadone restrictions relaxed during pandemic, but not for everyone." The article describes the recent relaxed federal restrictions for the drug, due to the...